163 related articles for article (PubMed ID: 15156293)
1. Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity.
Kennedy RC; Shearer MH; Lowe DB; Jumper CA; Chiriva-Internati M; Bright RK
Cancer Immunol Immunother; 2004 Nov; 53(11):987-94. PubMed ID: 15156293
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
[TBL] [Abstract][Full Text] [Related]
3. Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity.
Shearer MH; Dalgleish AG; Chanh TC; Kennedy RC
AIDS Res Hum Retroviruses; 2000 Jan; 16(1):77-86. PubMed ID: 10628819
[TBL] [Abstract][Full Text] [Related]
4. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
[TBL] [Abstract][Full Text] [Related]
5. Perturbation of the autoimmune network. II. Immunization with isologous idiotype induces auto-anti-idiotypic antibodies and suppresses the autoantibody response elicited by antigen: a serologic and cellular analysis.
Zanetti M; Glotz D; Rogers J
J Immunol; 1986 Nov; 137(10):3140-6. PubMed ID: 3490512
[TBL] [Abstract][Full Text] [Related]
6. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
Shearer MH; Bright RK; Kennedy RC
Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
Kennedy RC; Shearer MH; Watts AM; Bright RK
Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the idiotypic network in tumor immunity.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of idiotype expression. Induction of tolerance in an anti-idiotypic response.
Ortiz-Ortiz L; Weigle WO; Parks DE
J Exp Med; 1982 Sep; 156(3):898-911. PubMed ID: 7108445
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Sep; 139(6):2096-102. PubMed ID: 2442262
[TBL] [Abstract][Full Text] [Related]
11. Determination of idiotype-specific T cells in idiotype-vaccinated mice.
Heyfets A; Haimovich J; Hollander N
Immunol Lett; 2002 Mar; 80(3):207-13. PubMed ID: 11803054
[TBL] [Abstract][Full Text] [Related]
12. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules.
UytdeHaag F; Claassen I; Bunschoten H; Loggen H; Ottenhoff T; Teeuwsen V; Osterhaus A
J Mol Cell Immunol; 1987; 3(3):145-55. PubMed ID: 2908179
[TBL] [Abstract][Full Text] [Related]
13. Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen system.
Wikstrand CJ; Cole VR; Crotty LE; Sampson JH; Bigner DD
Cancer Immunol Immunother; 2002 Feb; 50(12):639-52. PubMed ID: 11862416
[TBL] [Abstract][Full Text] [Related]
14. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice.
Haimovich J; Kukulansky T; Weissman B; Hollander N
Cancer Immunol Immunother; 1999 Feb; 47(6):330-6. PubMed ID: 10203063
[TBL] [Abstract][Full Text] [Related]
15. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
16. Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3.
Yamamoto S; Yamamoto T; Saxton RE; Hoon DS; Irie RF
J Natl Cancer Inst; 1990 Nov; 82(22):1757-60. PubMed ID: 1700134
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with membrane-associated idiotype provides greater and more prolonged protection of animals from tumor challenge than the soluble form of idiotype.
Ghosh SK; White LM; Ghosh R; Bankert RB
J Immunol; 1990 Jul; 145(1):365-70. PubMed ID: 1972719
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.
Aldrich JF; Lowe DB; Shearer MH; Winn RE; Jumper CA; Bright RK; Kennedy RC
J Virol; 2011 Jul; 85(14):7216-24. PubMed ID: 21593176
[TBL] [Abstract][Full Text] [Related]
19. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
[TBL] [Abstract][Full Text] [Related]
20. Anti-idiotypic antibodies and the induction of specific tumor immunity.
Nepom GT; Hellström KE
Cancer Metastasis Rev; 1987; 6(4):489-502. PubMed ID: 2450687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
